Inventor · disambiguated record
Georgianna Harris
Also filed as: HARRIS GEORGIANNA · HARRIS GEORGIANNA S
12 granted patents·88 citations·filing 1993–2006
90Inventor score
Top patents by PatentIndex Score
12 records- 0180US6555358B1Polynucleotide encoding eimeria tenella cGMP dependent protein kinaseMERCK & CO INC·Filed 2000·Granted Apr 29, 2003·6 cites·9 claims
- 0274US7125700B2Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agentsMERCK & CO INC·Filed 2003·Granted Oct 24, 2006·2 cites·1 claims
- 0368US5710275A7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitorsMERCK & CO INC·Filed 1993·Granted Jan 20, 1998·22 cites·2 claims
- 0459US5763361A17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitorsMERCK & CO INC·Filed 1996·Granted Jun 9, 1998·13 cites·12 claims
- 0557US6352997B1Method of improving in-vitro fertilizationMERCK & CO INC·Filed 1999·Granted Mar 5, 2002·17 cites·6 claims
- 0655US7718390B2Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agentsMERIAL LTD·Filed 2006·Granted May 18, 2010·0 cites·4 claims
- 0755US5932559ATreatment of hyperandrogenic conditionsMERCK & CO INC·Filed 1996·Granted Aug 3, 1999·6 cites·20 claims
- 0847US5527807A7β-substituted-4-aza-5α-cholestan-3-ones as 5α reductase inhibitors useful in the prevention and treatment of hyperandrogenetic disordersMERCK & CO INC·Filed 1994·Granted Jun 18, 1996·6 cites·8 claims
- 0942US5935968AMethods for treating polycystic ovary syndromeMERCK & CO INC·Filed 1998·Granted Aug 10, 1999·6 cites·9 claims
- 1039US5656613ATreatment of hyperandrogenic conditionsMERCK & CO INC·Filed 1995·Granted Aug 12, 1997·5 cites·8 claims
- 1137US5756480ATreatment of hyperandrogenic conditionsMERCK & CO INC·Filed 1996·Granted May 26, 1998·4 cites·8 claims
- 1231US5962442AIrreversible inhibition of human 5α-reductaseMERCK & CO INC·Filed 1996·Granted Oct 5, 1999·1 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Georgianna Harris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →